AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Momotaro-Gene Inc.
  3. Financials
  4. Stockholders' equity

Momotaro-Gene Inc.【JP:E33052】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 2023-213-764.76%
Mar 31, 202232-88.87%
Mar 31, 2021287-49.01%
Mar 31, 2020563-34.81%
Mar 31, 2019864+15.50%
Mar 31, 2018748-10.62%
Mar 31, 2017837+550.87%
Mar 31, 2016129-472.54%
Mar 31, 2015-35+71.61%
Mar 31, 2014-20-372.24%
Mar 31, 20137-65.14%
Mar 31, 201221+0.63%
Mar 31, 201121-4.60%
Mar 31, 201022-54.09%
Mar 31, 200948+129.54%
Mar 31, 200821

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)